NCT05990179View on ClinicalTrials.gov

Genomic Uniformed-Screening Against Rare Disease In All Newborns

NARecruitingINTERVENTIONAL
Enrollment

100,000

Participants

Timeline

Start Date

September 6, 2022

Primary Completion Date

September 30, 2029

Study Completion Date

September 30, 2029

Conditions
Early Onset Genetic Conditions With Near Complete Penetrance
Interventions
OTHER

Genome sequencing-based newborn screening

Dried blood spots collected at birth for routine newborn screening will be used for genome sequencing based screening of a defined set of conditions.

Trial Locations (1)

10032

RECRUITING

Columbia University Irving Medical Center/NYP, New York

Sponsors

Collaborators (2)

Illumina, Inc.
GeneDx
All Listed Sponsors
collaborator

Illumina, Inc.

INDUSTRY

collaborator

GeneDx

UNKNOWN

collaborator

New York State Department of Health

OTHER_GOV

lead

Columbia University

OTHER